DK1736206T3 - Fysiologisk aktiv sammensætning og fremgangsmåde til fremstilling af denne - Google Patents

Fysiologisk aktiv sammensætning og fremgangsmåde til fremstilling af denne

Info

Publication number
DK1736206T3
DK1736206T3 DK05710527.2T DK05710527T DK1736206T3 DK 1736206 T3 DK1736206 T3 DK 1736206T3 DK 05710527 T DK05710527 T DK 05710527T DK 1736206 T3 DK1736206 T3 DK 1736206T3
Authority
DK
Denmark
Prior art keywords
basidiomycetes
fungus belonging
belonging
preparation
extract component
Prior art date
Application number
DK05710527.2T
Other languages
English (en)
Inventor
Tadashi Goino
Original Assignee
Tadashi Goino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tadashi Goino filed Critical Tadashi Goino
Application granted granted Critical
Publication of DK1736206T3 publication Critical patent/DK1736206T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
DK05710527.2T 2004-02-16 2005-02-16 Fysiologisk aktiv sammensætning og fremgangsmåde til fremstilling af denne DK1736206T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004038443 2004-02-16
PCT/JP2005/002824 WO2005077395A1 (ja) 2004-02-16 2005-02-16 生理活性組成物及びその製造方法

Publications (1)

Publication Number Publication Date
DK1736206T3 true DK1736206T3 (da) 2012-01-16

Family

ID=34857807

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05710527.2T DK1736206T3 (da) 2004-02-16 2005-02-16 Fysiologisk aktiv sammensætning og fremgangsmåde til fremstilling af denne

Country Status (8)

Country Link
US (1) US20070178118A1 (da)
EP (1) EP1736206B1 (da)
JP (1) JPWO2005077395A1 (da)
CN (1) CN1921871A (da)
AT (1) ATE529119T1 (da)
DK (1) DK1736206T3 (da)
ES (1) ES2372696T3 (da)
WO (1) WO2005077395A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (no) * 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
US7514085B2 (en) * 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
CN101396424B (zh) * 2008-07-30 2010-12-22 刘超 一种治疗和预防心脑血管疾病的药物组合物及其制备方法
EP2468253A1 (en) 2010-12-14 2012-06-27 InterMed Discovery GmbH Terpenoid spiro ketal compounds with LXR agonists activity, their use and formulations with them
CN102397302A (zh) * 2011-11-18 2012-04-04 四川省南充绿宝菌业科技有限公司 天然桑黄与原木赤灵芝活性物质提取物的生产方法及产品
CN113616737A (zh) * 2021-07-29 2021-11-09 山东臻稀生物科技有限公司 一种抗肿瘤且低毒无副作用的稀土多菌糖中药组方

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466455A (en) * 1990-10-18 1995-11-14 Huffstutler, Jr.; Miles C. Polyphase fluid-extraction process, resulting products and methods of use
RU2129003C1 (ru) * 1998-04-10 1999-04-20 Гоино Тадаши Средство, обладающее противоопухолевой активностью
JP2000143526A (ja) * 1998-11-13 2000-05-23 Asuke Yakuhin Kk 田七人参、霊芝、アガリクス茸を主成分とする糖尿・高血圧・肝機能改善剤およびこれの製造方法
CN1195534C (zh) * 2000-01-31 2005-04-06 五井野正 担子菌亚门和五加科提取物的生理活性组合物
JP2002000229A (ja) * 2000-06-23 2002-01-08 S F C:Kk 健康食品
WO2002038166A2 (en) * 2000-11-07 2002-05-16 University Of Chicago Ginseng berry extracts and pharmaceutical compositions therefrom
JP2002235084A (ja) * 2001-02-08 2002-08-23 Ishikawa Tennen Yakko Busshitsu Kenkyu Center 抗酸化剤
JP2002315570A (ja) * 2001-04-24 2002-10-29 Yukito Akiyama ＳＯＤ様物質を生産するＰｈｅｌｌｉｎｕｓｌｉｎｔｅｕｓの培養方法及びＳＯＤ様物質の製造方法
JP2002363092A (ja) * 2001-06-01 2002-12-18 Tadashi Goino 抗高脂血症組成物及びその製造方法
JP3619189B2 (ja) * 2001-12-26 2005-02-09 チハヤ株式会社 食品組成物及び食品組成物の製造方法
AU2003202159A1 (en) * 2002-04-08 2003-10-27 Ginseng Science Inc. Extract of processed panax genus plant, the preparation method thereof, and compositions containing the same
US7977379B2 (en) * 2002-05-15 2011-07-12 Bhn Co., Ltd. Method for angiogenesis inhibition or immunostimulation
JP4369096B2 (ja) * 2002-05-29 2009-11-18 正 五井野 賦形剤組成物

Also Published As

Publication number Publication date
EP1736206B1 (en) 2011-10-19
ATE529119T1 (de) 2011-11-15
ES2372696T3 (es) 2012-01-25
EP1736206A4 (en) 2009-07-29
WO2005077395A1 (ja) 2005-08-25
EP1736206A1 (en) 2006-12-27
US20070178118A1 (en) 2007-08-02
CN1921871A (zh) 2007-02-28
JPWO2005077395A1 (ja) 2007-10-18

Similar Documents

Publication Publication Date Title
Bhambri et al. Mushrooms as potential sources of active metabolites and medicines
Balandaykin et al. Review on chaga medicinal mushroom, Inonotus obliquus (higher basidiomycetes): Realm of medicinal applications and approaches on estimating its resource potential
Chang Global impact of edible and medicinal mushrooms on human welfare in the 21st century: nongreen revolution
DK1736206T3 (da) Fysiologisk aktiv sammensætning og fremgangsmåde til fremstilling af denne
Flores Arzú et al. A preliminary checklist of macrofungi of Guatemala, with notes on edibility and traditional knowledge
Ilyina et al. The Influence Of Hydrological Processing Of Vegetable Material As The Basic Component Of Substrate, On The Conversion Of Substances By Mycelium And The Yield Of Fungus Ganoderma Lucidum (Curt.: Fr.) P. Karst.
MY183349A (en) Use of lanostane and poria extract in treating diabetes
Üstün Makrofungusların besin değeri ve biyolojik etkileri
Van Griensven Culinary-medicinal mushrooms: Must action be taken?
Raghoonundon et al. Phlebopus (Boletales, Boletinellaceae), a peculiar bolete genus with widely consumed edible species and potential for economic development in tropical countries
Bolaniran et al. An appraisal of the metabolites, pharmacological and biotechnological significance of edible mushrooms
Gregori Medicinal mushrooms native to Slovenia
Chang The need for scientific validation of culinary-medicinal mushroom products
PE20060157A1 (es) Composicion natural que comprende extracto de monascus fungus y uva
Illana-Esteban El hongo maitake (Grifola frondosa) y su potencial terapéutico
CN104221703A (zh) 牛樟芝菌体培养方法及培养基底成份
Kengni Ayissi et al. Some noteworthy taxonomic variations in the complex wood-decayer Ganoderma resinaceum (Basidiomycota) with reference to collections from tropical Africa
Wu et al. Medicinal mushrooms and fungi from Yunnan Province, Part 1: Resources and diversity
Kaya et al. Determination of total phenolic content, antioxidant activity and eritadenine compound of wild mushrooms in Kayseri region and cultivated medicinal mushrooms.
Shin et al. Hypoglycemic effects of submerged culture of Ceriporia lacerata mycelium
GAFUR et al. Plant tolerance as a component of Ganoderma philippii management in Acacia mangium plantations
Klechak et al. The Biotechnology on the Basis of the Higner Basidiomycetous Mushrooms of Genus Coriolus Quel.
Thakur Wild Macro-Fungi from Northwest Himalayas: Future Prospects and Challenges
Vaario et al. 13C and 15N isotopic fractionations in matsutake sporocarps and surrounding substrates from a study site in Finland
Elkhateeb et al. Bioluminescent Mushrooms: Boon for Environmental Health